Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Loutet, Slade A ^a   Di Lorenzo, Flaviana ^b   Clarke, Chelsea ^a   Molinaro, Antonio ^b   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERIC ACID; ALKALINE PHOSPHATASE; CHLORAMPHENICOL; CYCLIC AMP BINDING PROTEIN; FLAGELLIN; GENTAMICIN; IMIPENEM; LECTIN; LIPOPOLYSACCHARIDE; NOVOBIOCIN; PERIPLASMIC PROTEIN; POLYMYXIN B; SERINE PROTEINASE; TETRACYCLINE; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA CENOCEPACIA; CELL MOTILITY; CULTURE MEDIUM; DISK DIFFUSION; DOWN REGULATION; ESCHERICHIA COLI; FLAGELLUM; GENE CONTROL; GENE FUNCTION; ISOGENIC STRAIN; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; NEGIBACTERIA;

BURKHOLDERIA CENOCEPACIA; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMYXIN B; TRANSCRIPTION, GENETIC;

EID: 80053175097     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-472     Document Type: Article

References (56)

1. Bottone EJ, Douglas SD, Rausen AR, Keusch GT. Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol 1975, 1(5):425-428. 275137, 1176612.
2. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104(2):206-210. 10.1016/S0022-3476(84)80993-2, 6420530.
3. Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 2008, 104(6):1539-1551. 10.1111/j.1365-2672.2007.03706.x, 18217926.
4. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342(8862):15-19. 10.1016/0140-6736(93)91881-L, 7686239.
5. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1206-1212.
6. Burns JL, Wadsworth CD, Barry JJ, Goodall CP. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 1996, 40(2):307-313. 163107, 8834871.
7. Gold R, Jin E, Levison H, Isles A, Fleming PC. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother 1983, 12(Suppl A):331-336.
8. Turner J, Cho Y, Dinh N-N, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998, 42(9):2206-2214. 105778, 9736536.
9. Loutet SA, Flannagan RS, Kooi C, Sokol PA, Valvano MA. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 2006, 188(6):2073-2080. 10.1128/JB.188.6.2073-2080.2006, 1428139, 16513737.
10. Moore RA, Hancock RE. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother 1986, 30(6):923-926. 180620, 3028253.
11. Cox AD, Wilkinson SG. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol Microbiol 1991, 5(3):641-646. 10.1111/j.1365-2958.1991.tb00735.x, 2046549.
12. Zhang L, Parente J, Harris SM, Woods DE, Hancock REW, Falla TJ. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 2005, 49(7):2921-2927. 10.1128/AAC.49.7.2921-2927.2005, 1168697, 15980369.
13. Eckert R, McHardy I, Yarbrough DK, He J, Qi F, Anderson MH, Shi W. Stability and activity in sputum of G10KHc, a potent anti-Pseudomonas antimicrobial peptide. Chemical biology & drug design 2007, 70(5):456-460. 10.1111/j.1747-0285.2007.00580.x, 21961054.
14. Loutet SA, Mussen LE, Flannagan RS, Valvano MA. A two-tier model of polymyxin B resistance in Burkholderia cenocepacia. Environ Microbiol Rep 2011, 3(2):278-285.
15. Ortega X, Silipo A, Saldías MS, Bates CC, Molinaro A, Valvano MA. Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B. J Biol Chem 2009, 284(32):21738-21751. 10.1074/jbc.M109.008532, 2755896, 19525227.
16. Loutet SA, Bartholdson SJ, Govan JR, Campopiano DJ, Valvano MA. Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia. Microbiology 2009, 155(6):2029-2039. 10.1099/mic.0.027607-0, 19383677.
17. Ortega XP, Cardona ST, Brown AR, Loutet SA, Flannagan RS, Campopiano DJ, Govan JR, Valvano MA. A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability. J Bacteriol 2007, 189(9):3639-3644. 10.1128/JB.00153-07, 1855895, 17337576.
18. Flannagan RS, Linn T, Valvano MA. A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ Microbiol 2008, 10(6):1652-1660. 10.1111/j.1462-2920.2008.01576.x, 18341581.
19. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 2000, 38(2):910-913. 86244, 10655415.
20. Silipo A, Molinaro A, Ieranò T, De Soyza A, Sturiale L, Garozzo D, Aldridge C, Corris PA, Anjam Khan CM, Lanzetta R, et al. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent Gram-negative bacterium Burkholderia cenocepacia ET-12 (Strain J2315). Chem Eur J 2007, 13(12):3501-3511.
21. Parker CT, Kloser AW, Schnaitman CA, Stein MA, Gottesman S, Gibson BW. Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12. J Bacteriol 1992, 174(8):2525-2538. 205891, 1348243.
22. Yamaguchi M, Sato K, Yukitake H, Noiri Y, Ebisu S, Nakayama K. A Porphyromonas gingivalis mutant defective in a putative glycosyltransferase exhibits defective biosynthesis of the polysaccharide portions of lipopolysaccharide, decreased gingipain activities, strong autoaggregation, and increased biofilm formation. Infect Immun 2010, 78(9):3801-3812. 10.1128/IAI.00071-10, 2937442, 20624909.
23. Agladze K, Wang X, Romeo T. Spatial periodicity of Escherichia coli K-12 biofilm microstructure initiates during a reversible, polar attachment phase of development and requires the polysaccharide adhesin PGA. J Bacteriol 2005, 187(24):8237-8246. 10.1128/JB.187.24.8237-8246.2005, 1317006, 16321928.
24. Moreira LM, Videira PA, Sousa SA, Leitão JH, Cunha MV, Sá-Correia I. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 2003, 312(2):323-333. 10.1016/j.bbrc.2003.10.118, 14637140.
25. Richäu JA, Leitäo JH, Sá-Correia I. Enzymes leading to the nucleotide sugar precursors for exopolysaccharide synthesis in Burkholderia cepacia. Biochem Biophys Res Commun 2000, 276(1):71-76. 10.1006/bbrc.2000.3438, 11006084.
26. Holden MT, Seth-Smith HM, Crossman LC, Sebaihia M, Bentley SD, Cerdeño-Tárraga AM, Thomson NR, Bason N, Quail MA, Sharp S, et al. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009, 191(1):261-277. 10.1128/JB.01230-08, 2612433, 18931103.
27. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, Brinkman FSL. The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics 2008, 24(23):2803-2804. 10.1093/bioinformatics/btn524, 2639269, 18842600.
28. Tatusov RL, Galperin MY, Natale DA, Koonin EV. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res 2000, 28(1):33-36. 10.1093/nar/28.1.33, 102395, 10592175.
29. Henrichsen J. Bacterial surface translocation: a survey and a classification. Bacteriol Rev 1972, 36(4):478-503. 408329, 4631369.
30. Kearns DB. A field guide to bacterial swarming motility. Nat Rev Micro 2010, 8(9):634-644.
31. Chung JW, Speert DP. Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host. Microbiology 2007, 153(1):206-214. 10.1099/mic.0.2006/000455-0, 17185549.
32. Huber B, Riedel K, Hentzer M, Heydorn A, Gotschlich A, Givskov M, Molin S, Eberl L. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 2001, 147(9):2517-2528.
33. Murray TS, Kazmierczak BI. Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J Bacteriol 2008, 190(8):2700-2708. 10.1128/JB.01620-07, 2293233, 18065549.
34. Folkesson A, Haagensen JAJ, Zampaloni C, Sternberg C, Molin S. Biofilm induced tolerance towards antimicrobial peptides. PLoS ONE 2008, 3(4):e1891. 10.1371/journal.pone.0001891, 2270907, 18382672.
35. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 2008, 68(1):223-240. 10.1111/j.1365-2958.2008.06152.x, 18312276.
36. Valvano MA, Messner P, Kosma P. Novel pathways for biosynthesis of nucleotide-activated glycero-manno-heptose precursors of bacterial glycoproteins and cell surface polysaccharides. Microbiology 2002, 148(Pt 7):1979-1989.
37. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002, 71:635-700. 10.1146/annurev.biochem.71.110601.135414, 2569852, 12045108.
38. Valvano MA, Marolda CL, Bittner M, Glaskin-Clay M, Simon TL, Klena JD. The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose. J Bacteriol 2000, 182(2):488-497. 10.1128/JB.182.2.488-497.2000, 94300, 10629197.
39. Freter A, Bowien B. Identification of a novel gene, aut, involved in autotrophic growth of Alcaligenes eutrophus. J Bacteriol 1994, 176(17):5401-5408. 196727, 8071217.
40. Nágy G, Danino V, Dobrindt U, Pallen M, Chaudhuri R, Emödy L, Hinton JC, Hacker J. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate. Infect Immun 2006, 74(10):5914-5925. 10.1128/IAI.00619-06, 1594928, 16988271.
41. Kooi C, Sokol PA. Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology 2009, 155(Pt 9):2818-2825.
42. Cummins J, Reen FJ, Baysse C, Mooij MJ, O'Gara F. Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. Microbiology 2009, 155(9):2826-2837. 10.1099/mic.0.025643-0, 19477905.
43. Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA, Hancock REW. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008, 76(9):4176-4182. 10.1128/IAI.00318-08, 2519444, 18591225.
44. Lai S, Tremblay J, Déziel E. Swarming motility: a multicellular behaviour conferring antimicrobial resistance. Environ Microbiol 2009, 11(1):126-136. 10.1111/j.1462-2920.2008.01747.x, 18793317.
45. Kim W, Killam T, Sood V, Surette MG. Swarm-cell differentiation in Salmonella enterica serovar Typhimurium results in elevated resistance to multiple antibiotics. J Bacteriol 2003, 185(10):3111-3117. 10.1128/JB.185.10.3111-3117.2003, 154059, 12730171.
46. Urban TA, Griffith A, Torok AM, Smolkin ME, Burns JL, Goldberg JB. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 2004, 72(9):5126-5134. 10.1128/IAI.72.9.5126-5134.2004, 517433, 15322006.
47. Tomich M, Herfst CA, Golden JW, Mohr CD. Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun 2002, 70(4):1799-1806. 10.1128/IAI.70.4.1799-1806.2002, 127839, 11895941.
48. Drevinek P, Holden M, Ge Z, Jones A, Ketchell I, Gill R, Mahenthiralingam E. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis 2008, 8:121. 10.1186/1471-2334-8-121, 2559838, 18801206.
49. Figurski DH, Helinski DR. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci USA 1979, 76(4):1648-1652. 10.1073/pnas.76.4.1648, 383447, 377280.
50. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983, 154(1):269-277. 217456, 6187729.
51. Schindler PR, Teuber M. Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob Agents Chemother 1975, 8(1):95-104. 429267, 169730.
52. Bader J, Teuber M. Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium. Z Naturforsch C 1973, 28(7):422-430.
53. Leiske DL, Karimpour-Fard A, Hume PS, Fairbanks BD, Gill RT. A comparison of alternative 60-mer probe designs in an in-situ synthesized oligonucleotide microarray. BMC Genomics 2006, 7:72. 10.1186/1471-2164-7-72, 1468409, 16595014.
54. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45. 10.1093/nar/29.9.e45, 55695, 11328886.
55. Cardona ST, Mueller CL, Valvano MA. Identification of essential operons with a rhamnose-inducible promoter in Burkholderia cenocepacia. Appl Environ Microbiol 2006, 72(4):2547-2555. 10.1128/AEM.72.4.2547-2555.2006, 1448982, 16597956.
56. Holloway BW. Genetic Recombination in Pseudomonas aeruginosa. J Gen Microbiol 1955, 13(3):572-581.